These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8195643)

  • 41. Production and some properties of monoclonal antibodies against human pancreatic secretory trypsin inhibitor.
    Nagata K; Ide M; Yoshida N; Kono M; Kurobe M; Hayashi K
    Biochem Int; 1990 Sep; 21(6):1065-72. PubMed ID: 1706918
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ski promotes tumor growth through abrogation of transforming growth factor-beta signaling in pancreatic cancer.
    Heider TR; Lyman S; Schoonhoven R; Behrns KE
    Ann Surg; 2007 Jul; 246(1):61-8. PubMed ID: 17592292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monitor peptide (rat pancreatic secretory trypsin inhibitor) directly stimulates the proliferation of the nontransformed intestinal epithelial cell line, IEC-6.
    Fukuda M; Fujiyama Y; Sasaki M; Andoh A; Bamba T; Fushiki T
    Digestion; 1998; 59(4):326-30. PubMed ID: 9693203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human pancreatic adenocarcinomas express parathyroid hormone-related protein.
    Bouvet M; Nardin SR; Burton DW; Behling C; Carethers JM; Moossa AR; Deftos LJ
    J Clin Endocrinol Metab; 2001 Jan; 86(1):310-6. PubMed ID: 11232017
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dehydroepiandrosterone-sulfate inhibits pancreatic carcinoma cell proliferation in vitro and in vivo.
    Melvin WS; Boros LG; Muscarella P; Brandes JL; Johnson JA; Fisher WE; Schirmer WJ; Ellison EC
    Surgery; 1997 Apr; 121(4):392-7. PubMed ID: 9122868
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pancreatic secretory trypsin inhibitor reduces multi-organ injury caused by gut ischemia/reperfusion in mice.
    Playford RJ; Marchbank T
    PLoS One; 2020; 15(1):e0227059. PubMed ID: 31923181
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Induction of p21waf1 expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells.
    Grau AM; Zhang L; Wang W; Ruan S; Evans DB; Abbruzzese JL; Zhang W; Chiao PJ
    Cancer Res; 1997 Sep; 57(18):3929-34. PubMed ID: 9307274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Elevation of circulating monitor peptide/pancreatic secretory trypsin inhibitor-I (PSTI-61) after turpentine-induced inflammation in rats: hepatocytes produce it as an acute phase reactant.
    Uda K; Murata A; Nishijima J; Doi S; Tomita N; Ogawa M; Mori T
    J Surg Res; 1994 Nov; 57(5):563-8. PubMed ID: 7526044
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human pancreatic secretory trypsin inhibitor. Distribution, actions and possible role in mucosal integrity and repair.
    Marchbank T; Freeman TC; Playford RJ
    Digestion; 1998; 59(3):167-74. PubMed ID: 9643675
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Site-directed mutagenesis of human pancreatic secretory trypsin inhibitor.
    Kikuchi N; Nagata K; Shin M; Mitsushima K; Teraoka H; Yoshida N
    J Biochem; 1989 Dec; 106(6):1059-63. PubMed ID: 2628423
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells.
    Hashimoto K; Ethridge RT; Evers BM
    Int J Gastrointest Cancer; 2002; 32(1):7-22. PubMed ID: 12630765
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Production of enzymes and enzyme inhibitors in neoplastic tissues].
    Ogawa M; Nakamura Y; Yamamoto T; Nishide T; Emi M; Matsuura N; Matsuda K; Shibata T; Horii A; Tomita N
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):731-9. PubMed ID: 2421643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutations within the reactive-site region of human pancreatic secretory trypsin inhibitor confer alpha-thrombin and factor Xa inhibitory activities.
    Katoh T; Tamaki M; Kikuchi N; Teraoka H; Nagata K; Yoshida N
    Biosci Biotechnol Biochem; 1997 Feb; 61(2):389-91. PubMed ID: 9058985
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Protein engineering of human pancreatic secretory trypsin inhibitor (PSTI)].
    Teraoka H; Yoshida N
    Tanpakushitsu Kakusan Koso; 1990 Oct; 35(14):2654-64. PubMed ID: 2267344
    [No Abstract]   [Full Text] [Related]  

  • 56. Pancreatic secretory trypsin inhibitor causes autocrine-mediated migration and invasion in bladder cancer and phosphorylates the EGF receptor, Akt2 and Akt3, and ERK1 and ERK2.
    Marchbank T; Mahmood A; Playford RJ
    Am J Physiol Renal Physiol; 2013 Aug; 305(3):F382-9. PubMed ID: 23698120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer.
    Itakura J; Ishiwata T; Shen B; Kornmann M; Korc M
    Int J Cancer; 2000 Jan; 85(1):27-34. PubMed ID: 10585578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
    Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
    Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metastatic-associated biological properties and differential gene expression profiles in established highly liver and peritoneal metastatic cell lines of human pancreatic cancer.
    Ohno K; Hata F; Nishimori H; Yasoshima T; Yanai Y; Sogahata K; Ezoe E; Tanaka H; Kamiguchi K; Isomura H; Denno R; Sato N; Hirata K
    J Exp Clin Cancer Res; 2003 Dec; 22(4):623-31. PubMed ID: 15053306
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunohistochemical localization of pancreatic secretory trypsin inhibitor in malignant pancreatic endocrine tumors.
    Kamisawa T; Tu Y; Egawa N; Ishiwata J; Tsuruta K; Okamoto A; Hayashi Y; Koike M
    Cancer Detect Prev; 2000; 24(6):572-8. PubMed ID: 11198271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.